WCG IRB转发了
We are thrilled to introduce IBC+. WCG’s IBC+ is accelerating biosafety oversight to advance your gene transfer research. Ensure faster and more efficient reviews without compromising the rigor of IBC. WCG’s IBC+ reinvents standard document processing, resulting in a 50% reduction in turnaround timelines and shortened site activation by multiple months.? Combined with WCG’s IRB+, which reduces study timelines by months and lowers overall costs associated with clinical trial delays, IBC+ ensures that sponsors can achieve site activation and study start-up faster for trials involving genetically engineered products. This dual approach provides unparalleled efficiency and a streamlined pathway for both ethical and biosafety reviews. Accelerate your gene transfer study today with WCG’s IBC+. Read the full press release at?https://lnkd.in/eRcfHDy3. Learn more at https://lnkd.in/ehigzf99. #WCG #IBC #IBCReview #Biosafety #StudyReview #cellandgenetherapy #genetransfer?